3M Drug-In-Adhesive Delivery
In passive transdermal systems, the drug diffuses through the skin where it can act locally or penetrate the capillaries for systemic effect. Passive systems, because of the barrier properties of the skin, are most useful in delivering small molecule drugs.
3M has pioneered several advancements in passive delivery, including our single-layer and multi-layer drug-in-adhesive (DIA) technology that has become the industry standard.
The 3M DIA systems offer a versatile platform that provides compatibility with a wide variety of drugs. This type of transdermal patch is less likely to deliver too much medication and continued advancements allow this system to deliver more than one drug in a single patch resulting in added patient convenience.
Because the adhesive layer not only serves to adhere the patch layers together and to the skin, but also contains the drug, DIA systems offer advantages in reduced size and thickness and improved conformability to the application site, helping drive patient preference.
With more than 30 years of transdermal experience, 3M excels at integrating adhesive, drug and components into a single, simple system that provides superior product stability and optimal system performance throughout the duration of the wear period. We deliver the core advantages you need to help ensure your technical success:
- Expertise in customizing solutions to fit drug formulation needs
- Access to material and process technology expertise from across the 3M scientific community
- Regulatory and toxicology support
- Streamlined pathway through development
- Contract pharma manufacturing services
